In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. The medical ...

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

JMP Securities analyst David Turkaly reiterated a Hold rating on Globus Medical (GMED – Research Report) today. The company’s shares opened ...

From acquisitions and new leadership, here are six key updates from spine and orthopedic device companies since March 26: 1.

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. Three ...

Globus Medical has a fifty-two week low of $49.33 and a fifty-two week high of $94.93. Globus Medical ( NYSE:GMED – Get Free Report ) last posted its earnings results on Thursday, February 20th.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.